Doctor communication and handling legal restrictions on the pharmaceutical market in Poland

23 November 2010

Doctor’s surgery remains the most typical place where doctors are willing to meet representatives of pharmaceutical companies. On the other hand, most doctors have also heard of modern forms of pharma marketing, according to a survey conducted by market research group PMR among doctors in Poland, the results of which have been presented in the report titled Modern and traditional forms of effective pharmaceutical marketing.

In the study, PMR asked doctors in Poland questions about their knowledge of the specific forms of communication between doctors and pharmaceutical companies. It appears that the most typical place where doctors meet representatives of pharmaceutical companies remains the doctor’s surgery - during working hours (99%) or off-working hours (97%), as well as meetings at scientific conferences (100%) - almost all doctors have heard of this possibility.

Phone contact (mostly involving the arrangement of subsequent appointments) and contacts during post-marketing surveillance are also among the generally popular ways of liaising with pharmaceutical companies (each garnering over 90% of responses), says PMR.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical